-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Fuscin
Category | Human immunodeficiency Virus (HIV) |
CAS | 83-85-2 |
Description | Produced by the strain of Oidiodendron fuscum Ag 122 and Camb 111, Fuscin has resistance to gram-positive bacteria and mycobacterium (weak) activity. Fuscin is also an anti-HIV compound and antagonist of CKR-5 (CCR5). |
Product Information
Synonyms | 9,10-Dihydro-5-hydroxy-4,8,8-trimethyl-2-H,4-H-benzo(1,2-b-4,3-c)-dipyran-2,6(8H)-dione; 2-Hydroxy-4,8,8-trimethyl-9,10-dihydro-4H-pyrano[3,2-f]isochromene-5,6-dione |
IUPAC Name | 5-hydroxy-4,8,8-trimethyl-9,10-dihydro-4H-pyrano[4,3-f]chromene-2,6-dione |
Molecular Weight | 276.28 |
Molecular Formula | C15H16O5 |
Canonical SMILES | CC1C2=C(C(=O)C3=C(C2=CC(=O)O1)CCC(O3)(C)C)O |
InChI | InChI=1S/C15H16O5/c1-7-11-9(6-10(16)19-7)8-4-5-15(2,3)20-14(8)13(18)12(11)17/h6-7,17H,4-5H2,1-3H3 |
InChIKey | OSJKAGRXDVEZQO-UHFFFAOYSA-N |
Boiling Point | 417.6°C at 760 mmHg |
Melting Point | 230°C |
Flash Point | 155.5°C |
Purity | ≥95% |
Density | 1.35 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | Orange Flake Crystalline |
Storage | -20°C |
Complexity | 618 |
Exact Mass | 276.09977361 |
Index Of Refraction | 1.594 |
PSA | 72.83000 |
Target | CCR; HIV; Bacterial; Mitochondrial Metabolism; Endogenous Metabolite |
XLogP3-AA | 0.8 |